Mind Probes, Inc.

Cincinnati, OH 45219

SBIR Award Summary

Total Number of Awards 6
Total Value of Awards $320K
First Award Date 08/01/99
Most Recent Award Date 09/30/01

Key Personnel

Last Name Name Awards Contact
Mulchahey James Jeffrey Mulchahey 1
Zemlan Frank P Zemlan 5

6 Awards Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/30/01 - 03/30/02

DESCRIPTION (provided by applicant): The objective of this Phase I application is to develop a sensitive biomarker for quantifying neuronal damage resulting from acute alcohol abuse. Specifically, we will determine whether elevated serum levels of cleaved-tau observed after acute alcohol abuse reflect neuronal damage....

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/20/00 - 06/30/01

The objective of this Phase I application is to develop a sensitive serum- based biomarker for drug-induced neuronal damage in humans. Specifically, we will assess whether elevated serum levels of MAP-tau observed after acetaminophen overdose (OD) reflect neuronal damage. MAP-tau is a cytoskeletal protein primarily localized in neuronal axons; a...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 07/15/00 - 01/14/01

The objective of this Phase I application is to develop a serum-based biomarker for acute neuronal degeneration. This test is needed to assess several clinical indications including traumatic brain injury (TBI), as well as, a surrogate endpoint for assessing the efficacy of neuroprotective agents. We have developed a sandwich ELISA for quantifyi...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 06/01/00 - 05/31/01

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/20/99 - 03/19/00

The objective of this proposal is to develop a laboratory test for acute neuronal degeneration. Such a test is needed for several clinical indications including traumatic brain injury (TBI) as well as, staging patients for drug trials of neuroprotective agents. The proposed laboratory test will quantify levels of neurofilament proteins. Neurof...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 08/01/99 - 07/31/00

DESCRIPTION: (Applicant's abstract) The objective of this proposal is to develop a laboratory test for quantifying acute neuronal degeneration. Such a test is needed for several clinical indications including traumatic brain injury (TBI) as well as staging patients for drug trials of neuroprotective agents. The proposed laboratory test will quan...